Advanced search
Publication Cover
Cancer Investigation Volume 22, 2004 - Issue 6
Submit an article Journal homepage
56
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): A Trial of the Eastern Cooperative Oncology Group

Corey J. Langer Fox Chase Cancer Center, 7701 Burholme Ave., Philadelphia, Pennsylvania, 19111, USA
, M.D.,
Yi Li Dana Farber Cancer Institute, Boston, MassachusettsUSA
, Ph.D.,
Timothy Jennings Albany Medical College, Albany, New YorkUSA
, M.D.,
Ronald C. DeConti H. Lee Moffitt Cancer Center, Tampa, FloridaUSA
, M.D.,
Suresh Nair Geisinger Medical Center, Danville, PennsylvaniaUSA
, M.D.,
Roger B. Cohen Fox Chase Cancer Center, 7701 Burholme Ave., Philadelphia, Pennsylvania, 19111, USA
, M.D. &
Arlene A. Forastiere Johns Hopkins University, Baltimore, MarylandUSA
, M.D. show all
Pages 823-831 | Published online: 23 Nov 2004

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jean-Pascal Machiels & Sandra Schmitz. (2011) Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy 11:3, pages 359-371.
Read now
Daris Ferrari, Carla Codecà, Jessica Fiore, Andrea Luciani & Paolo Foa. (2009) A review on the treatment of relapsed/metastatic head and neck cancer. Expert Opinion on Pharmacotherapy 10:16, pages 2625-2632.
Read now

Articles from other publishers (11)

Mallika Lala, Diana Chirovsky, Jonathan D. Cheng & Kapil Mayawala. (2018) Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review. Oral Oncology 84, pages 108-120.
Crossref
Jean-Pascal Machiels & Sandra Schmitz. 2017. Critical Issues in Head and Neck Oncology. Critical Issues in Head and Neck Oncology 221 231 .
Diocésio A.P. de Andrade & Jean-Pascal Machiels. (2012) Treatment options for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, who progress after platinum-based chemotherapy. Current Opinion in Oncology 24:3, pages 211-217.
Crossref
Yann Molin & Jérôme Fayette. (2011) Current chemotherapies for recurrent/metastatic head and neck cancer. Anti-Cancer Drugs 22:7, pages 621-625.
Crossref
Hui Huang, Michael Menefee, Maureen Edgerly, Sen Zhuang, Herb Kotz, Marianne Poruchynsky, Lyn Mickley Huff, Susan Bates & Tito Fojo. (2010) A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research 16:5, pages 1634-1641.
Crossref
Missak HaigentzJr.Jr.. 2009. Complications in Head and Neck Surgery. Complications in Head and Neck Surgery 181 188 .
Corey J. Langer. (2008) Targeted therapy in head and neck cancer. Cancer 112:12, pages 2635-2645.
Crossref
B.A. Burtness, J. Manola, R. Axelrod, A. Argiris & A.A. Forastiere. (2008) A randomized phase II study of ixabepilone (BMS-247550) given daily × 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study. Annals of Oncology 19:5, pages 977-983.
Crossref
George R. BlumenscheinJr.Jr., Merrill S. Kies, Vassiliki A. Papadimitrakopoulou, Charles Lu, Ashok J. Kumar, Justin L. Ricker, Judy H. Chiao, Cong Chen & Stanley R. Frankel. (2007) Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Investigational New Drugs 26:1, pages 81-87.
Crossref
Pol M. Specenier & Jan B. Vermorken. (2007) Neoadjuvant chemotherapy in head and neck cancer: Should it be revisited?. Cancer Letters 256:2, pages 166-177.
Crossref
A. Dimitrios Colevas. (2006) Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology 24:17, pages 2644-2652.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.